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Abstract: It was established through in vivo T1 measurements
at low magnetic fields that tumour cells display proton T1
values that are markedly longer than those shown by healthy
tissue. Moreover, it has been found that the elongation of T1
parallels the aggressiveness of the investigated tumour. The T1
lengthening is associated with an enhanced water exchange rate
across the transcytolemmal membrane through an overexpres-
sion/upregulation of GLUT1 and Na+/K+ ATPase transport-
ers. It follows that the intracellular water lifetime represents
a hallmark of tumour cells that can be easily monitored by
measuring T1 at different magnetic field strengths ranging from
0.2 to 200 mT.
Magnetic resonance imaging (MRI) has played a key role
in the field of oncology over the last few decades. The
prominent role of MRI relies on its superb spatial and
temporal resolution, and its diagnostic power basically arises
from the differences in the longitudinal (T1) and transverse
(T2) proton relaxation times between healthy and patholog-
ical tissues. However, at the magnetic field strength of the
currently availableMRI scanners, changes inT1 do not appear
to be sensitive enough to report on the particular aspects of
the tumour stage.[1] However, there is widespread opinion
that at low magnetic field strength, the marked increase in R1
(= 1/T1) observed in biological tissues might be beneficial
towards improving the MRI diagnostic potential in tumour
phenotyping.[2]
Herein, it is shown that the in vivo acquisition of 1/T1
nuclear magnetic resonance dispersion (NMRD) profiles
(from 0.2 to 200 mT) fully supports this expectation as the
observed R1 values at low magnetic fields (< 0.2 T) enable the
clear discrimination between tumours characterised by differ-
ent metastatic potentials.
The 1/T1 NMRD profiles were acquired on fast field
cycling (FFC) relaxometers, which are able to switch the
Figure 1. A) The FFC experiment: The nuclear spin polarization is built
up during the pre-polarization phase, at Bp. Relaxation occurs during
the evolution period (t) at Br, then the NMR signal is detected at Bd.
The sequence is repeated, staggering t each time. For Br>7 MHz, the
cycle starts in the absence of any polarization field. B) Photographs of
the FFC-NMR relaxometer showing the introduced modifications for
the in vivo acquisition: a) the FFC magnet; b) the mouse holding
system; c) the transmitter/receiver coil around the mouse’s leg.
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magnetic field between different field strengths during the
measurement procedure.[3] A field cycle overcomes the
problem of the low sensitivity at low fields and allows for
the rapid acquisition of an NMRD profile (Figure 1A). The
most diffuse FFC relaxometers are designed for measure-
ments of liquid or solid small samples (< 1 cm3). To perform
this study, prototype FFC-NMR equipment was developed by
STELAR (Mede, PV, Italy) for the acquisition of in vivo
NMRD profiles on animal models. To host a mouse (ca. 20 g),
a 0.5 T wide bore FFC magnet was used with the implemen-
tation of a dedicated 11 mm transmitter/receiver solenoid
detection coil placed around the mouseQs leg (Figure 1B)
where the tumour graft was located.
In this study, mouse mammary adenocarcinoma cells,
namely TS/A, 4T1, and 168FARN, were injected into the
muscle of the hind limb to obtain tumour xenografts suitable
for in vivo studies. The three cell lines were selected because
they display different aggressiveness and metastatic potential
(i.e., 168FARN<TS/A< 4T1).[4] When the tumour mass
covers 65–85% of the leg, the T2-weighted images were
acquired by MRI (1 T; Figure 2A). The NMRD data points
were obtained by using the procedure depicted in Figure 1A
(16 t values).
The fitting of the magnetization decay curves (Mz) for the
determination of T1 was carried out by means of the
monoexponential Bloch equation, despite the fact that the
Mz decay may display biexponential characteristics (see
below). A simple inspection of the obtained profiles allowed
us to clearly distinguish healthy from tumour tissue (Fig-
ure 2B) as the tumour invariantly showed lower R1 values.
Furthermore, the large differences observed in the R1 data at
low fields provided insight into particular characteristics of
the considered tumour grafts. The elongation of T1 followed
the tumour size in different ways for the three models,
essentially reflecting the differences in their aggressiveness
(Figure 2C). The observed behaviour clearly showed that the
differences in T1 between the healthy and tumour tissue were
significantly larger at low magnetic field strengths. The
absence of extended necrotic/cystic areas was assessed by
T2-weighted image analysis (see the Supporting Information,
Figure S1). As the averaged signal intensities measured on the
three tumour models were not significantly different, it was
possible to exclude that T1 elongation was mainly caused by
the presence of microscopic necrotic areas.
To gain more insight into the factors determining the
observed behaviour, one needs to remember that eachR1 data
point represents an average of the water R1 in different tissue
microenvironments, basically 1) the extracellular (EX) space
with an averaged R1ex value and 2) the intracellular (IN)
compartment with a more restricted water mobility, with
a relaxation of R1in, with Vex and Vin being the respective
volume fractions. The intravascular volume may be neglected
as it represents a tiny percentage of the total value.[5] Water
can cross the barriers between the two compartments, thus
contributing to mixing, to some extent, towards the R1s of the
IN and EX compartments. Therefore, tin and tex (the IN and
EXwater residence times, respectively) have to be introduced
in the model (Figure 3). Such exchange rates are correlated,
according to the mass balance, through the volume fractions
of the two compartments:
tin > Vex ¼ tex > V in ð1Þ
According to this bicompartmental model, the evolution
time of MZ is dependent on the relationship between the
Figure 2. A) T2-weighted MRI of the tumour-bearing mouse (4T1
graft). B) 1/T1 NMRD profile of a mouse leg tissue before (day 0) and
after the intramuscular injection of one million 4T1 cells. C) NMRD
profiles of the tumour tissues grown on hind limbs: 4T1 (~), TS/A
(&), and 168FARN (*) acquired 11:2, 13:3, and 25:1 days after
intramuscular injection, respectively. R1
tum is the averaged relaxation
rate normalized to the tumour mass fraction compared to the whole
hind limb. Error bars report the standard deviation (SD).
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absolute values of the “relaxation” term, jR1in@R1ex j , and an
“exchange” term jkin+kex j (where kin= 1/tin and kex= 1/tex) in
a relationship that has been previously defined as the NMR
“shutter speed”.[6]
On the basis of this model (Figure 3), a monoexponential
time course ofMZ is expected only in a fast-exchange regime,
that is, when the condition jkin+kex j@ jR1in@R1ex j is met. In
this case, analysis of the saturation recovery (SR) data
provides a single R1 value, which corresponds to the average
between R1in and R1ex weighted by the volume fractions of the
two sites. Conversely, when there is no exchange between the
two compartments, the recovery ofMZ will be biexponential,
thus enabling the accurate determination of both R1in and R1ex
values through a simple biexponential analysis of the SR data.
In between, there is the intermediate-exchange region in
which the time evolution ofMZ can still be biexponential, but
the R1s obtained from the fitting of the SR data can be
“contaminated” by the exchange occurring between the two
compartments.
The greater the exchange rate between the two compart-
ments, the larger the T1 contamination arising by the EX
compartment (endowed with a lower volume fraction). To
estimate the different parameters, the MZ recovery was then
re-acquired over an extended number of t intervals (n= 48),
to improve the sampling of both fast and slow T1 components.
Moreover, an experimental approach to assessR1ex values was
pursued by measuring the 1/T1 profile of Matrigel (Figure 4).
Matrigel is a gelatinous protein mixture secreted by
Engelbreth–Holm–Swarm mouse sarcoma cells. It is a model
of the EX environment found in many tissues and used as
a substrate for cell culturing.[7] The similarity of the NMRD
profiles acquired on matrigel incubated for 72 h (Figure S2) in
the absence or in the presence of 4T1, TS/A, and 168FARN
cells supports the view that the presence of factors secreted by
cells (e.g., proteins, enzymes,
metabolites) does not affect the
observed water proton R1s. This
finding made us confident of the
use of the Matrigel model to mimic
the EX matrix compartment. By
introducing the T1 values obtained
for the Matrigel solution as the
“long” T1 component, a good fit of
the Mz recovery curves was
obtained using the mode equation
for two-site exchange (2SX model;
see Section V in the Supporting
Information). The Vex was allowed
to vary within a feasible range, in
accordance with results already
reported in the literature (0.09–
0.19 for a healthy mouse hind limb,
0.15–0.5 for a tumourous mouse
hind limb).[6b,8] The values of tin
and Vex given by the fitting are
listed in Table 1.
The most striking result from
the fitting procedure is that the
Figure 3. The water exchange regime and the resulting MZ value in a schematic representation of the
relationship between the compartmentalized system formed by the IN and the EX space. In the case
of intermediate exchange, aS and R1S are the fraction and the rate constant for the apparent
component with the shorter T1 (R1S=1/T1S); (1@aS)=aL and R1L are the fraction and rate constant for
the apparent component with the longer T1 (R1L=1/T1L), and t is the running time for recovery by
relaxation.
Figure 4. R1in of mouse leg tissue: healthy legs and tumour-bearing
legs. Values were obtained from the NMRD data by fitting to the 2SX
model. For comparison, the R1 values measured for Matrigel are
reported (^). Error bars indicate SDs from at least five independent
experiments.





Vex tin [s] tin [s]
muscle leg 0.14:0.02 1.24:0.25 –
4T1 0.22:0.08 0.68:0.20 0.023:0.009
TS/A 0.20:0.02 0.99:0.19 0.039:0.012
168FARN 0.15:0.01 1.12:0.32 0.111:0.014
[a] Data acquired on healthy and tumour-bearing mouse legs between
0.01 and 10 MHz (number of Br : 8) were simultaneously fitted; the
mean:SD is calculated from at least five independent experiments.
[b] Data acquired on cells in the presence of Gd-HPDO3A; the
mean:SD is calculated from at least 4 independent experiments.
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decrease in tin to indicate that the water exchange rate across
the plasmalemmal membrane is a distinctive hallmark that
differentiates between muscle (representative of healthy
cells) and tumour cells. This finding clearly reports on the
peculiar characteristics of the given tumour cell type. In fact,
the IN water lifetime tin values reported in Table 1 for three
breast cancer cell lines are inversely proportional to their
metastatic potential. 4T1 cells are highly metastatic and form
metastases in many organs (lungs, lymph nodes, brain,
bone),[4a] TS/A cells display limited metastatic activity in the
lungs,[4a,9] and 168FARN cells only produce local micro-
metastases.[9]
Support for this conclusion was gained by measuring tin
values of the different cell lines in vitro, following a well-
established relaxometric procedure.[10] For this purpose,
measurements were carried out at 0.5 T in the presence of
increasing amounts of the paramagnetic Gd-HPDO3A com-
plex in the EX space of cell suspensions. Then, the inversion
recovery data were analysed according to the 2SX model.[6b]
The obtained tin values are reported in Table 1. Although the
drastically different experimental conditions caused a large
decrease for the tin values obtained in vitro, they maintained
analogous differences among the cell lines as observed
in vivo, suggesting common determinants for tin/tex.
Finally, it is worth noting that the IN relaxation times
(R1in) appear rather insensitive to the cell type characteristics
(Figure 4). These results confirm that the R1 values of IN
water are markedly higher than those of EX water. IN water
is embedded in an organized and immobilized protein
network (cytoskeleton) that can be considered as a dynamic
gel, and is more ordered than EX water.[11] Figure 4 clearly
indicates that IN water is the principal component of the
typical 1/T1 NMRD tissue profile whereas EX water has
a higher mobility and a lower R1. The latter result, well
understandable for vascular water, may appear a bit odd for
the EX matrix, which contains a high protein concentration.
However, the experimental finding of low Matrigel R1 values
confirms the hypothesis that this low value is most likely due
to the higher water mobility of these proteins.
It follows that the main determinant of the elongation of
T1 in tumour cells is tin, which decreases as the aggressiveness
increases.
Examples of 1/T1 NMRD profiles acquired on fresh or
thawed surgical specimens have been reported previously.[12]
However, the use of ex vivo samples has the flaw that it
cannot take into account the dynamics of water mobility,
which is a key term determining the NMRD profile.
Why do tumour cells display a shorter tin value than
healthy cells? The answer may rely on the increased glycolytic
activity of tumour cells, which leads to an increased produc-
tion of metabolites with a consequent increase in the IN
osmotic pressure. The tumour cells cope with this issue by
increasing the exchange rate of water with the external
compartment. Therefore, to gain further support for our
views, the expression of glucose transporter GLUT-1 and
Na+/K+ ATPase was evaluated by immunofluorescence
(Figure 5).
To unambiguously demonstrate that the expression of
these transporters is directly correlated with the decrease in
tin observed for the three cell lines (4T1<TS/A< 168FARN),
the effect of the inhibition of GLUT-1 and Na+/K+ ATPase
was assessed. Cells were incubated for 24 h in the presence of
5 mm of WZB117,[13] the GLUT-1 inhibitor, or 100 mm of
Ouabain,[14] the Na+/K+ ATPase inhibitor. Then, tin was
determined on the cell lines “in vitro” following the above
described procedure. Cell vitality, determined by MTTassays,
was > 90% also after WZB117 and Ouabain treatment (see
Figures S9 and S10). The treated 4T1 and TS/A cells showed
a marked increase in tin (Figure 6), confirming the suggestion
about the relevant role of the expression of this transporter in
the modulation of transcytolemmal water exchange rates. As
expected, the longer tin of 168FARN is less dependent on
both inhibitors.
The results reported herein show that 1/T1 NMRD
profiles measured in vivo on implanted mammary tumours
clearly allow for the assessment of marked T1 increases, with
Figure 5. Immunofluorescence confocal images (63X). Cells were
stained for GLUT-1 (upper panels) and Na+/K+ ATPase (bottom).
Nuclei were counterstained with DAPI (blue).
Figure 6. tin values determined “in vitro” on cells with and without
GLUT-1 and Na+/K+ ATPase inhibition. Errors bars indicate SDs from
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respect to healthy tissues, that occur at low magnetic fields
(< 0.2 T). This achievement may open new horizons for the
non-invasive evaluation of tumour metabolic phenotypes by
providing useful and more detailed information related to the
metastatic propensity of the tumour without requiring the
administration of exogenous contrast agents. This finding
outlines the dependence of the observed T1 on the trans-
cytolemmal water exchange rate when the two involved
compartments have a sufficiently different R1, as observed at
low magnetic fields (< 0.2 T). The simultaneous fitting of the
Mz over an extended range of magnetic field strengths allows
for a good estimation of tin. Water transport across the plasma
membrane is crucial to cell function. Cell water content and
cell volume are related to the concentration of IN osmotically
active compounds as well as to the EX tonicity. Cations,
anions, and other metabolites are transported across the cell
membrane by active transporters whose up/downregulation
occurring in the presence of a pathological state can act as
a specific reporter of the cellular state. tin reports on the
activities of a number of transporters, and collectively, it may
represent a hallmark of tumour-cell aggressiveness. The tin is
the result of contributions from a number of sources,
including overexpression/upregulation of transporters such
as GLUT-1 and Na+/K+ ATPase. We may conclude that the
measurement of transmembrane permeability provides
insight for more specific assessments of the pathophysiolog-
ical status of tumours. Even though FFC-NMR instrumenta-
tion is not endowed with spatial resolution, the fundamental
knowledge obtained in this study can enable new diagnostic
opportunities in oncology that were previously unrecognized
and are potentially transferable to the two prototype human-
whole-body-sized FFC-MRI scanners recently built at Aber-
deen University by Lurie and co-workers. Pilot studies
performed on these FFC-MRI scanners have already dem-
onstrated the potential use of FFC-MRI in a range of several
pathologies such us musculoskeletal and cardiovascular dis-
eases.[15]
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